146 related articles for article (PubMed ID: 10952619)
1. Successful trovafloxacin prophylaxis against experimental streptococcal aortic valve endocarditis.
Katsarolis I; Pefanis A; Iliopoulos D; Siaperas P; Karayiannakos P; Giamarellou H
Antimicrob Agents Chemother; 2000 Sep; 44(9):2564-6. PubMed ID: 10952619
[TBL] [Abstract][Full Text] [Related]
2. Successful moxifloxacin prophylaxis against experimental streptococcal aortic valve endocarditis.
Sakka V; Galani L; Pefanis A; Iliopoulos D; Athanasopoulos G; Donta I; Giamarellou H
J Antimicrob Chemother; 2005 Dec; 56(6):1160-2. PubMed ID: 16204339
[TBL] [Abstract][Full Text] [Related]
3. Trovafloxacin treatment of viridans group Streptococcus experimental endocarditis.
Piper KE; Rouse MS; Ronningen KL; Steckelberg JM; Wilson WR; Patel R
Antimicrob Agents Chemother; 2000 Sep; 44(9):2554-6. PubMed ID: 10952616
[TBL] [Abstract][Full Text] [Related]
4. Linezolid in prophylaxis against experimental aortic valve endocarditis due to Streptococcus oralis or Enterococcus faecalis.
Athanassopoulos G; Pefanis A; Sakka V; Iliopoulos D; Perrea D; Giamarellou H
Antimicrob Agents Chemother; 2006 Feb; 50(2):654-7. PubMed ID: 16436723
[TBL] [Abstract][Full Text] [Related]
5. Successful single-dose teicoplanin prophylaxis against experimental streptococcal, enterococcal, and staphylococcal aortic valve endocarditis.
Perdikaris GS; Pefanis A; Giamarellou H; Nikolopoulos A; Margaris EP; Donta I; Tsitsika A; Karayiannakos P
Antimicrob Agents Chemother; 1997 Sep; 41(9):1916-21. PubMed ID: 9303384
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis.
Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 1999 Jan; 43(1):77-84. PubMed ID: 9869569
[TBL] [Abstract][Full Text] [Related]
7. Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae.
Kim YS; Liu Q; Chow LL; Täuber MG
Antimicrob Agents Chemother; 1997 May; 41(5):1186-9. PubMed ID: 9145898
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of trovafloxacin, ciprofloxacin and ampicillin against Streptococcus pneumoniae in a murine sepsis model.
Lacy MK; Nicolau DP; Banevicius MA; Nightingale CH; Quintiliani R
J Antimicrob Chemother; 1999 Oct; 44(4):477-81. PubMed ID: 10588309
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of trovafloxacin, a new quinolone antibiotic, in experimental staphylococcal endocarditis due to oxacillin-resistant strains.
Bayer AS; Li C; Ing M
Antimicrob Agents Chemother; 1998 Jul; 42(7):1837-41. PubMed ID: 9661030
[TBL] [Abstract][Full Text] [Related]
10. Single-oral-dose azithromycin prophylaxis against experimental streptococcal or staphylococcal aortic valve endocarditis.
Tsitsika A; Pefanis A; Perdikaris GS; Donta I; Karayiannakos P; Giamarellou H
Antimicrob Agents Chemother; 2000 Jun; 44(6):1754-6. PubMed ID: 10817749
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of trovafloxacin against experimental Staphylococcus aureus endocarditis.
Kaatz GW; Seo SM; Aeschlimann JR; Houlihan HH; Mercier RC; Rybak MJ
Antimicrob Agents Chemother; 1998 Feb; 42(2):254-6. PubMed ID: 9527768
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus.
Chambers HF; Xiang Q; Liu ; Chow LL; Hackbarth C
Antimicrob Agents Chemother; 1999 Nov; 43(11):2742-6. PubMed ID: 10543757
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of trovafloxacin in experimental endocarditis caused by ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus.
Kim YS; Liu Q; Chow LL; Chambers HF; Täuber MG
Antimicrob Agents Chemother; 1998 Dec; 42(12):3325-7. PubMed ID: 9835540
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of treatment with penicillin, ceftriaxone, trovafloxacin, quinupristin-dalfopristin and vancomycin in experimental endocarditis due to penicillin- and ceftriaxone-resistant Streptococcus pneumoniae.
López Fornas F; Martínez García F; Pérez Salmeron J; Roldán Conesa D; Cortés Sanchez R; García Alberola A; Ruíz Gómez J; Gómez Gómez J; Valdés Chávarri M
J Antimicrob Chemother; 2001 May; 47(5):623-9. PubMed ID: 11328774
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy of experimental streptococcal endocarditis. 3. Failure of a bacteriostatic agent (tetracycline) in prophylaxis.
Southwick FS; Durack DT
J Clin Pathol; 1974 Apr; 27(4):261-4. PubMed ID: 4604215
[TBL] [Abstract][Full Text] [Related]
16. Successful single-dose amoxicillin prophylaxis against experimental streptococcal endocarditis: evidence for two mechanisms of protection.
Glauser MP; Bernard JP; Moreillon P; Francioli P
J Infect Dis; 1983 Mar; 147(3):568-75. PubMed ID: 6833800
[TBL] [Abstract][Full Text] [Related]
17. Daptomycin (LY146032) for prevention and treatment of experimental aortic valve endocarditis in rabbits.
Kennedy S; Chambers HF
Antimicrob Agents Chemother; 1989 Sep; 33(9):1522-5. PubMed ID: 2554799
[TBL] [Abstract][Full Text] [Related]
18. Treatment of experimental Staphylococcus epidermidis endophthalmitis with oral trovafloxacin.
Ng EW; Samiy N; Ruoff KL; Cousins FV; Hooper DC; von Gunten S; D'Amico DJ; Baker AS
Am J Ophthalmol; 1998 Aug; 126(2):278-87. PubMed ID: 9727522
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic prophylaxis against streptomycin-resistant and -susceptible Streptococcus faecalis endocarditis in rabbits.
Guze PA; Kalmanson GM; Freedman LR; Ishida K; Guze LB
Antimicrob Agents Chemother; 1983 Oct; 24(4):514-7. PubMed ID: 6418063
[TBL] [Abstract][Full Text] [Related]
20. Response of complicated methicillin-resistant Staphylococcus aureus endocarditis to the addition of trovafloxacin.
Eckart RE; Hospenthal DR; Fishbain JT
Pharmacotherapy; 2000 May; 20(5):589-92. PubMed ID: 10809347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
